Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which contains over 400 links to online copies of actual merger and acquisition contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.
“Merger and Acquisition Agreements in Biopharma” which is available at http://www.piribo.com/
The report provides an overview of the structure of merger and acquisition deals and reviews the leading M&A deals since 2000. It includes numerous case studies to enable understanding of both pure merger/acquisition deals and multicomponent deals where acquisition forms a part.
Analysts say that a majority of these deals are acquisitions where one company acquires the target company in a cash and/or equity transaction.
Authors of the report say that contract documents provide the answers to numerous questions about a prospective partner's stance on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The study contains a comprehensive listing of the top 50 pharma companies with information on the M&A frequency and acquired companies since 2000. This is followed by a comprehensive listing of M&A contract documents along with key deal terms available in the public domain. Each deal title links via Weblink to an online version of the actual contract document, and the contract document collection can be used offline on CD-Rom.
“Merger & Acquisition Agreements in Biopharma” is available in pdf format from Piribo. For more information, go to:
http://www.piribo.com/
Piribo product ID: CTP102
